subject: PUBCHEM.COMPOUND:24950485

subject_name: Cobicistat

object_name: acute leukemia of ambiguous lineage


subject: PUBCHEM.COMPOUND:24950485

object_name: acute biphenotypic leukemia

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:24950485

object_name: mixed phenotype acute leukemia


subject: PUBCHEM.COMPOUND:24950485

object_name: acute myeloid leukemia by FAB classification


subject: PUBCHEM.COMPOUND:24950485

object_name: acute myeloid leukemia


subject: PUBCHEM.COMPOUND:24950485

object_name: acute lymphoblastic leukemia


subject: CHEBI:31547

subject_name: Eplerenone

object_name: central serous chorioretinopathy

tested_intervention: yes


subject: PUBCHEM.COMPOUND:11422859

object_name: myeloid neoplasm


subject: UMLS:C0958645

subject_name: R alpha methylhistamine


subject: CHEBI:137228

subject_name: Desmeninol


subject: CHEBI:233413

subject_name: Denifanstat

object_name: Childhood Astrocytoma


subject: CHEBI:233413

object_name: glioma susceptibility 1


subject: CHEBI:233413

object_name: astrocytic tumor


subject: CHEBI:233413

object_name: astrocytoma


subject: MESH:C000717092


subject: MESH:C000717092


subject: MESH:C000717092


subject: MESH:C000717092


subject: UNII:26X6QU3JUB

subject_name: BIFIDOBACTERIUM LONGUM R0175

object_name: irritable bowel syndrome


subject: UNII:9332PFV3K3

subject_name: LACTOBACILLUS PARACASEI HA-196


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: septic shock


subject: UMLS:C3896757

subject_name: TGFBR1 Inhibitor TEW-7197

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C1704263

subject_name: green tea extract

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1704263

object_name: metabolic syndrome X


subject: DRUGBANK:DB14307

subject_name: Green tea leaf


subject: DRUGBANK:DB14307


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: idiopathic juvenile osteoporosis


subject: CHEBI:2567

object_name: Feline osteogenesis imperfecta


subject: CHEBI:2567

object_name: Bone fracture


subject: CHEBI:2567

object_name: Fractured


subject: CHEBI:2567

object_name: Bone density below reference range (finding)


subject: UNII:4988K7X26P

subject_name: Fosamax


subject: UNII:4988K7X26P


subject: UNII:4988K7X26P


subject: UNII:4988K7X26P


subject: UNII:4988K7X26P


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: adrenal cortex carcinoma


subject: UMLS:C4053601


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Post-Operative Pain


subject: DRUGBANK:DB17676

subject_name: Oxabact

object_name: urolithiasis


subject: DRUGBANK:DB17676

object_name: nephrolithiasis


subject: DRUGBANK:DB17676

object_name: nephrolithiasis susceptibility caused by SLC26A1


subject: DRUGBANK:DB17676

object_name: Kidney Calculi


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: acute kidney failure


subject: CHEBI:201431

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: kidney neoplasm


subject: PUBCHEM.COMPOUND:136924190

object_name: kidney cancer


subject: PUBCHEM.COMPOUND:136924190

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: clear cell renal carcinoma


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Pelvis fracture


subject: CHEBI:119915

object_name: Hip Fracture, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:60802


subject: CHEBI:80630

subject_name: Irinotecan

object_name: head and neck cancer


subject: CHEBI:53315

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] macromolecule

object_name: cystic fibrosis


subject: CHEBI:60588

subject_name: poly[9,9-bis((6'-N,N,N-trimethylammonium)hexyl)fluorenylene phenylene dibromide] polymer


subject: CHEBI:31980

subject_name: Perflutren


subject: UniProtKB:P35763

subject_name: PERF_RAT Perforin-1 (sprot)


subject: PR:000003466


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Advanced prostate cancer


subject: UMLS:C5847502

subject_name: Agave Inulin

object_name: cerebral palsy


subject: UMLS:C5847502

object_name: Chronic constipation


subject: CHEBI:90205

subject_name: Plitidepsin

object_name: lymphoma


subject: PUBCHEM.COMPOUND:73313844

subject_name: Dehydrodidemnin B


subject: UMLS:C0388638

subject_name: plitidepsin


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: UMLS:C3473058

subject_name: Amyvid

object_name: Alzheimer disease type 1


subject: UMLS:C3473058

object_name: Alzheimer disease


subject: CHEBI:71013

subject_name: Perampanel

object_name: Status epilepticus


subject: CHEBI:71013

object_name: cardiac arrest


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: peritoneal carcinomatosis


subject: CHEBI:24814

object_name: endometriosis


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: atopic eczema


subject: CHEBI:39428

subject_name: Perflenapent

object_name: glioblastoma


subject: CHEBI:39428

object_name: Brain Stem Glioblastoma


subject: CHEBI:39428

object_name: glioma susceptibility 1


subject: UMLS:C3896802


subject: UMLS:C3896802


subject: UMLS:C3896802


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: Acute appendicitis NOS (disorder)


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:50730

subject_name: Montelukast

object_name: Albuminuria


subject: CHEBI:32026

subject_name: Poloxalene

object_name: sickle cell disease


subject: CHEBI:63451

subject_name: Infigratinib

object_name: liver cancer


subject: CHEBI:63451

object_name: liver neoplasm


subject: CHEBI:63451

object_name: Adult Liver Carcinoma


subject: CHEBI:63451

object_name: liver carcinoma


subject: CHEBI:177833

subject_name: Cilengitide

object_name: malignant soft tissue neoplasm


subject: CHEBI:177833

object_name: sarcoma


subject: UMLS:C0764377


subject: UMLS:C0764377


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Affective Disorders, Psychotic


subject: UMLS:C0701303


subject: UMLS:C0701303

object_name: Depressed mood


subject: CHEBI:27470

subject_name: Folic acid

object_name: anemia of prematurity


subject: CHEBI:27470

object_name: Extreme immaturity


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Breast Cancer Lymphedema


subject: CHEBI:60791

subject_name: Xylocard

object_name: lumbar spinal stenosis


subject: CHEBI:60791

object_name: spinal stenosis


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: UMLS:C0086466

subject_name: Injectables


subject: UMLS:C0086466


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:57834

object_name: myocardial ischemia


subject: CHEBI:57834

object_name: Family history of ischemic heart disease


subject: CHEBI:57834

object_name: cardiovascular disorder


subject: CHEBI:57834

object_name: hypertensive heart disease


subject: CHEBI:57834

object_name: type 2 diabetes mellitus


subject: CHEBI:57834

object_name: Cognitive impairment


subject: CHEBI:57834

object_name: myocardial infarction


subject: CHEBI:57834

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:57834

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:57834

object_name: Diastolic dysfunction


subject: CHEBI:57834

object_name: cognitive disorder


subject: CHEBI:57834

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:57834

object_name: metabolic syndrome X


subject: CHEBI:57834

object_name: outcomes general quality of life


subject: CHEBI:57834

object_name: Perceived quality of life


subject: CHEBI:57834

object_name: Good quality of life


subject: CHEBI:57834

object_name: Inflammation


subject: CHEBI:57834

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:57834

object_name: obesity


subject: CHEBI:57834

object_name: Obesity, CTCAE


subject: CHEBI:16610

subject_name: Spermidine

object_name: myocardial ischemia


subject: CHEBI:16610

object_name: Family history of ischemic heart disease


subject: CHEBI:16610

object_name: cardiovascular disorder


subject: CHEBI:16610

object_name: hypertensive heart disease


subject: CHEBI:16610

object_name: type 2 diabetes mellitus


subject: CHEBI:16610

object_name: Cognitive impairment


subject: CHEBI:16610

object_name: myocardial infarction


subject: CHEBI:16610

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:16610

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:16610

object_name: Diastolic dysfunction


subject: CHEBI:16610

object_name: cognitive disorder


subject: CHEBI:16610

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:16610

object_name: metabolic syndrome X


subject: CHEBI:16610

object_name: outcomes general quality of life


subject: CHEBI:16610

object_name: Perceived quality of life


subject: CHEBI:16610

object_name: Good quality of life


subject: CHEBI:16610

object_name: Inflammation


subject: CHEBI:16610

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16610

object_name: obesity


subject: CHEBI:16610

object_name: Obesity, CTCAE


subject: CHEBI:132268

subject_name: Dacomitinib

object_name: skin squamous cell carcinoma


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEBI:9130

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C4549041

object_name: osteogenesis imperfecta


subject: UNII:D6OMY2L0WA

subject_name: Epcoritamab

object_name: primary central nervous system lymphoma


subject: UMLS:C5206892

subject_name: epcoritamab


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: nephrotoxicity


subject: CHEBI:9168

subject_name: Sirolimus

object_name: connective tissue disorder


subject: UMLS:C5239399

subject_name: Ad5-SGE-REIC/Dkk-3 MTG-201

object_name: malignant pleural mesothelioma


subject: CHEBI:140407

subject_name: Ceftobiprole

object_name: staphylococcal infection


subject: CHEBI:140407

object_name: Staphylococcal Skin Infections


subject: CHEBI:140407

object_name: streptococcal infection


subject: CHEBI:2704

subject_name: Anastrozole

object_name: Ambulatory Status - Mastectomy


subject: CHEBI:2704

object_name: Generalised illness


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: UMLS:C1443122

subject_name: Artemisia dracunculus antigen

object_name: glucose intolerance


subject: UMLS:C1443122

object_name: Glucose Intolerance, CTCAE


subject: UMLS:C4082210

subject_name: Artemisia dracunculus whole extract


subject: UMLS:C4082210


subject: CHEBI:135207

subject_name: Clofedanol

object_name: myocardial ischemia


subject: CHEBI:135207

object_name: angina unstable


subject: CHEBI:135207

object_name: cardiovascular surgery result: angina


subject: CHEBI:135207

object_name: Angina pectoris


subject: CHEBI:15365

subject_name: Aspirin


subject: CHEBI:15365


subject: PUBCHEM.COMPOUND:118665873

subject_name: Clifutinib

object_name: adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:118665873

object_name: Leukemia - acute myeloid leukemia (AML)


subject: PUBCHEM.COMPOUND:118665873

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:118665873

object_name: acute myeloid leukemia


subject: UMLS:C5556443


subject: UMLS:C5556443


subject: UMLS:C5556443


subject: UMLS:C5556443


subject: UNII:2372V1TKXK

subject_name: Lanadelumab

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C4044724


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic Cutaneous Melanoma


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Recurrent Adult Liver Carcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UNII:9G6U5L461Q

subject_name: Icotinib

object_name: Carcinoma breast stage IV


subject: CHEBI:16118

subject_name: Berberine

object_name: Dyslipidemia


subject: CHEBI:4907

subject_name: Etidronic acid

object_name: Arterial calcification


subject: CHEBI:68554

subject_name: Deferiprone

object_name: Friedreich ataxia


subject: UNII:QQA9MLH692

subject_name: Tafasitamab

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C2987409


subject: PUBCHEM.COMPOUND:126481870

subject_name: valemetostat


subject: PUBCHEM.COMPOUND:126481870

object_name: non-Hodgkin lymphoma


subject: UNII:60RD0234VE

subject_name: Valemetostat


subject: UNII:60RD0234VE


subject: CHEBI:24996

subject_name: lactate

object_name: Peritoneal membrane disorder


subject: CHEBI:24996

object_name: end stage renal failure


subject: CHEBI:24996

object_name: chronic kidney disease


subject: CHEBI:24996

object_name: Chronic uremia


subject: CHEBI:42111

subject_name: D-Lactic acid


subject: CHEBI:42111


subject: CHEBI:42111


subject: CHEBI:42111


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:16411


subject: CHEBI:16411


subject: CHEBI:16411


subject: MESH:D007773

subject_name: Lactates


subject: MESH:D007773


subject: MESH:D007773


subject: MESH:D007773


subject: CHEBI:78320

subject_name: Lactic acid


subject: CHEBI:78320


subject: CHEBI:231594

subject_name: Norgestrel

object_name: diabetic kidney disease


subject: UMLS:C5239507

subject_name: eFT 226

object_name: Adult Solid Neoplasm


subject: CHEBI:230352

subject_name: Desidustat


subject: UMLS:C5198569

subject_name: desidustat


subject: CHEMBL.COMPOUND:CHEMBL2108210

subject_name: LAVENDER OIL

object_name: Dyssomnias


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: Sleep abnormality


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: type 2 diabetes mellitus


subject: CHEMBL.COMPOUND:CHEMBL2108210

object_name: sleep disorder


subject: CHEBI:6801

subject_name: Metformin

object_name: Immune dysregulation


subject: CHEBI:28044

subject_name: phenylalanine

object_name: phenylketonuria


subject: CHEBI:28044

object_name: classic phenylketonuria


subject: CHEBI:64312

subject_name: Memantine

object_name: binge eating


subject: CHEBI:135593

subject_name: Ecabet

object_name: dry eye syndrome


subject: UNII:98DE7VN88D

subject_name: huMov 19

object_name: HER2/Neu Negative


subject: UNII:98DE7VN88D

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:98DE7VN88D

object_name: Estrogen Receptor Negative


subject: UNII:98DE7VN88D

object_name: Progesterone Receptor Negative


subject: UNII:98DE7VN88D

object_name: Folate Receptor Alpha Positive


subject: UMLS:C3640818

object_name: HER2/Neu Negative


subject: UMLS:C3640818

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640818

object_name: Estrogen Receptor Negative


subject: UMLS:C3640818

object_name: Progesterone Receptor Negative


subject: UMLS:C3640818

object_name: Folate Receptor Alpha Positive


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: thrombophilia due to thrombin defect


subject: UNII:52CMI0WC3Y

object_name: Venous thrombosis after immobility


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Constipation


subject: CHEBI:41423

object_name: Constipation, CTCAE


subject: CHEBI:41423

object_name: Nausea, CTCAE_5


subject: CHEBI:41423

object_name: Nausea


subject: CHEBI:41423

object_name: Nausea, CTCAE_3


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:42797

subject_name: Gabapentin

object_name: opioid use


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:7852

subject_name: Oxycodone


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:7852


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: PUBCHEM.COMPOUND:11993742

subject_name: Percocet


subject: PUBCHEM.COMPOUND:11993742


subject: PUBCHEM.COMPOUND:11993742


subject: PUBCHEM.COMPOUND:11993742


subject: PUBCHEM.COMPOUND:11993742


subject: PUBCHEM.COMPOUND:11993742


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:46195


subject: UMLS:C0483514

subject_name: Vicodin


subject: UMLS:C0483514


subject: UMLS:C0483514


subject: UMLS:C0483514


subject: UMLS:C0483514


subject: UMLS:C0483514


subject: CHEBI:7774

subject_name: Zofran


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7774


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:15407

subject_name: Ephedrine

object_name: Complication of anesthesia


subject: CHEBI:33569

subject_name: noradrenaline


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UNII:T6Q3060U91

subject_name: motesanib diphosphate

object_name: fallopian tube carcinoma


subject: UNII:T6Q3060U91

object_name: fallopian tube cancer


subject: UNII:T6Q3060U91

object_name: ovarian cancer


subject: UNII:T6Q3060U91

object_name: ovarian neoplasm


subject: UNII:T6Q3060U91

object_name: ovarian carcinoma


subject: UNII:T6Q3060U91

object_name: peritoneum cancer


subject: CHEBI:51098

subject_name: Motesanib


subject: CHEBI:51098


subject: CHEBI:51098


subject: CHEBI:51098


subject: CHEBI:51098


subject: CHEBI:51098


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:145372

object_name: non-small cell lung carcinoma


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: female reproductive organ cancer


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Recurrent Childhood Ependymoma


subject: CHEBI:38940

object_name: pediatric infratentorial ependymoma


subject: CHEBI:38940

object_name: pediatric supratentorial ependymoma


subject: CHEBI:38940

object_name: Recurrent Childhood Subependymal Giant Cell Astrocytoma


subject: CHEBI:38940

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: CHEBI:38940

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: CHEBI:38940

object_name: Childhood Mixed Glioma


subject: CHEBI:38940

object_name: Childhood Cerebellar Anaplastic Astrocytoma


subject: CHEBI:38940

object_name: Childhood Cerebral Anaplastic Astrocytoma


subject: CHEBI:38940

object_name: childhood oligodendroglioma


subject: CHEBI:38940

object_name: childhood cerebral astrocytoma


subject: CHEBI:91450

subject_name: Sapanisertib

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:91450

object_name: B-cell childhood acute lymphoblastic leukemia


subject: CHEBI:91450

object_name: B-cell adult acute lymphocytic leukemia


subject: CHEBI:91450

object_name: B-cell acute lymphoblastic leukemia


subject: CHEBI:91450

object_name: Infant T Acute Lymphoblastic Leukemia


subject: CHEBI:91450

object_name: Pre T-ALL


subject: CHEBI:91450

object_name: T-cell childhood acute lymphocytic leukemia


subject: CHEBI:91450

object_name: T-cell adult acute lymphocytic leukemia


subject: CHEBI:91450

object_name: Refractory Adult Acute Lymphoblastic Leukemia


subject: CHEBI:91450

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:91450

object_name: Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:91450

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:91450

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:91450

object_name: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative


subject: CHEBI:82977

subject_name: Daclatasvir

object_name: HCV coinfection


subject: CHEBI:94463


subject: PUBCHEM.COMPOUND:66811198

subject_name: SIMEPREVIR


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Drug withdrawal syndrome


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:31300

subject_name: BOSENTAN

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:31300

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:31300

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:51450

subject_name: Bosentan


subject: CHEBI:51450


subject: CHEBI:51450


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Refractory Cutaneous Melanoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:25812

subject_name: Ozone

object_name: myocardial ischemia


subject: CHEBI:25812

object_name: Family history of ischemic heart disease


subject: UMLS:C0678023

subject_name: LMB-9 Immunotoxin

object_name: ovarian cancer


subject: UMLS:C0678023

object_name: ovarian neoplasm


subject: UMLS:C0678023

object_name: ovarian carcinoma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: papillary renal cell carcinoma


subject: CHEBI:71219

object_name: chromophobe renal cell carcinoma


subject: CHEBI:71219

object_name: sarcomatoid renal cell carcinoma


subject: CHEBI:71219

object_name: kidney oncocytoma


subject: CHEBI:71219

object_name: kidney medullary carcinoma


subject: CHEBI:71219

object_name: collecting duct carcinoma


subject: CHEBI:4911

subject_name: Etoposide

object_name: Previously Treated Myelodysplastic Syndrome


subject: MESH:C000614959

object_name: thyroid tumor


subject: MESH:C000614959

object_name: thyroid cancer


subject: UMLS:C5556787

subject_name: Anti-LAG-3/Anti-PD-L1 Bispecific Antibody IBI323

object_name: non-small cell lung carcinoma


subject: CHEBI:3535

subject_name: Cephalexin

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:3535

object_name: acute myeloid leukemia


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:10023

subject_name: Voriconazole


subject: CHEBI:10023


subject: PUBCHEM.COMPOUND:53396339

subject_name: Erismodegib

object_name: breast neoplasm


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:145373

subject_name: Pexidartinib

object_name: Moderate Hepatic Insufficiency


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Unresectable Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:31355

object_name: Unresectable Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:31355

object_name: Unresectable Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:31355

object_name: Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:31355

object_name: Unresectable Fallopian Tube Endometrioid Adenocarcinoma


subject: CHEBI:31355

object_name: Unresectable Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: Stage III Ovarian Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IV Ovarian Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage III Fallopian Tube Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage III Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: CHEBI:95089

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: CHEBI:95089


subject: CHEBI:95089


subject: CHEBI:95089

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:95089

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:95089


subject: CHEBI:95089


subject: CHEBI:95089


subject: CHEBI:95089


subject: CHEBI:95089

object_name: Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:95089

object_name: Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:95089

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:95089

object_name: Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Unresectable Ovarian Endometrioid Adenocarcinoma


subject: CHEBI:45863

object_name: Unresectable Ovarian High Grade Serous Adenocarcinoma


subject: CHEBI:45863

object_name: Unresectable Fallopian Tube High Grade Serous Adenocarcinoma


subject: CHEBI:45863

object_name: Unresectable Primary Peritoneal High Grade Serous Adenocarcinoma


subject: CHEBI:45863

object_name: Unresectable Fallopian Tube Endometrioid Adenocarcinoma


subject: CHEBI:45863

object_name: Unresectable Primary Peritoneal Endometrioid Adenocarcinoma


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:5790

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:5790

object_name: Malignant Solid Neoplasm


subject: CHEBI:17347

subject_name: Testosterone

object_name: chronic kidney disease


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: retinitis pigmentosa


subject: UMLS:C0678449

object_name: retinitis pigmentosa 1


subject: UMLS:C0678449

object_name: retinal degeneration


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UNII:HD4TW8S2VK

subject_name: Pridopidine

object_name: Huntington disease


subject: UMLS:C3541376

subject_name: Non-nucleoside reverse transcriptase inhibitors

object_name: HIV infection


subject: UMLS:C3537104

subject_name: Non-nucleoside Reverse Transcriptase Inhibitor


subject: UNII:T4H8FMA7IM

subject_name: Siltuximab

object_name: acute respiratory distress syndrome


subject: UNII:T4H8FMA7IM

object_name: adult acute respiratory distress syndrome


subject: UNII:T4H8FMA7IM

object_name: respiratory tract infectious disorder


subject: UNII:T4H8FMA7IM

object_name: respiratory system disorder


subject: UNII:T4H8FMA7IM

object_name: lung disorder


subject: UNII:T4H8FMA7IM

object_name: pneumonia


subject: UNII:T4H8FMA7IM

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:145499

subject_name: Donepezil

object_name: Chronic low back pain


subject: UMLS:C2741958

object_name: cystic fibrosis


subject: CHEBI:188074

object_name: Macroalbuminuric nephropathy due to diabetes mellitus


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: UMLS:C5239502

subject_name: Salovum

object_name: Effects of chemotherapy


subject: UMLS:C5239502

object_name: brain edema


subject: CHEBI:6121

subject_name: Ketamine

object_name: suicidal ideas


subject: CHEBI:28240

subject_name: dichloroacetate

object_name: type 2 diabetes mellitus


subject: CHEBI:28240

object_name: Insulin resistance


subject: CHEBI:36386

subject_name: Dichloroacetic acid


subject: CHEBI:36386


subject: UNII:D07V79Q44T

object_name: plasma cell myeloma


subject: UMLS:C1566164


subject: UNII:V5Y646AW8S

object_name: Post-thoracotomy pain syndrome


subject: CHEBI:2618

subject_name: Amantadine


subject: CHEBI:6538

subject_name: Loratadine


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid


subject: CHEBI:64356

subject_name: Pregabalin


subject: CHEBI:60802

subject_name: ropivacaine

object_name: URETHROCUTANEOUS FISTULA


subject: CHEBI:60802

object_name: hypospadias


subject: CHEBI:60802

object_name: Penile hypospadias


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Menopause present (finding)


subject: CHEBI:16822

object_name: Menopause


subject: CHEBI:15354

subject_name: Choline


subject: CHEBI:15354


subject: UMLS:C0723213

subject_name: Santyl

object_name: decubitus ulcer


subject: UMLS:C5706347

subject_name: Anti-Claudin18.2/Anti-CD3 Bispecific Antibody QLS31905

object_name: pancreatic neoplasm


subject: UMLS:C5706347

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706347

object_name: malignant pancreatic neoplasm


subject: CHEBI:49575

subject_name: Diazepam

object_name: peripheral vertigo


subject: UNII:DRP53ZDY6H


subject: UNII:667440B6Z7

object_name: methamphetamine dependence


subject: UNII:667440B6Z7

object_name: Harmful pattern of use of methamphetamine


subject: UNII:667440B6Z7

object_name: Harmful pattern of substance use


subject: UNII:667440B6Z7

object_name: substance abuse


subject: PUBCHEM.COMPOUND:44560493


subject: PUBCHEM.COMPOUND:44560493


subject: PUBCHEM.COMPOUND:44560493


subject: PUBCHEM.COMPOUND:44560493


subject: UMLS:C3502022

subject_name: RTI 336


subject: UMLS:C3502022


subject: UMLS:C3502022


subject: UMLS:C3502022


subject: CHEBI:151315

subject_name: Heparin

object_name: arteriovenous hemangioma/malformation


subject: CHEBI:230519

subject_name: heparin sodium


subject: CHEBI:33569

subject_name: noradrenaline

object_name: liver failure


subject: CHEBI:18357

subject_name: Norepinephrine


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: acute lymphoblastic leukemia


subject: CHEBI:131174

subject_name: Navitoclax

object_name: diffuse large B-cell lymphoma


subject: CHEBI:131174

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:131174

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UMLS:C3828882

subject_name: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine

object_name: cytomegalovirus infection


subject: UMLS:C3828882

object_name: lymphoblastic lymphoma


subject: UMLS:C3828882

object_name: Adult Lymphoblastic Lymphoma


subject: UMLS:C3828882

object_name: Childhood Lymphoblastic Lymphoma


subject: UMLS:C3828882

object_name: Lymphadenopathy


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: epilepsy


subject: CHEBI:8869

object_name: Bone fracture


subject: CHEBI:8869

object_name: Fractured


subject: CHEBI:6121

subject_name: Ketamine

object_name: Dyskinesia


subject: CHEBI:6121

object_name: nervous system disorder


subject: CHEBI:6121

object_name: CNS disorder


subject: CHEBI:6121

object_name: Neurologic Manifestations


subject: CHEBI:6121

object_name: movement disorder


subject: UMLS:C2355268

object_name: melanoma


subject: UMLS:C2355268

object_name: malignant soft tissue neoplasm


subject: UMLS:C2355268

object_name: sarcoma


subject: UMLS:C2355268

object_name: High grade glioma


subject: UMLS:C2355268

object_name: malignant glioma


subject: UMLS:C2355268

object_name: lung cancer


subject: UMLS:C2355268

object_name: lung neoplasm


subject: UMLS:C2355268

object_name: lung carcinoma


subject: UMLS:C2355268

object_name: head and neck cancer


subject: PR:000032307

subject_name: mastermind-like domain-containing protein 1


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: PR:000032307


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: digestive system cancer


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: UMLS:C1882413

subject_name: Poly(ADP-ribose) Polymerase Inhibitors

object_name: Homologous Recombination Deficiency


subject: UMLS:C1882413


subject: UMLS:C4019076

subject_name: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]


subject: UMLS:C4019076


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: AIDS


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: prostate carcinoma


subject: UNII:8M7YSN2KII

object_name: prostate cancer


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UNII:H57D26Z9YK

subject_name: remestemcel-l

object_name: graft versus host disease


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:4026

object_name: subcutaneous panniculitis-like T-cell lymphoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UNII:KUW1QG1ZM3

subject_name: siplizumab


subject: UNII:KUW1QG1ZM3

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: UNII:KUW1QG1ZM3

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:KUW1QG1ZM3


subject: UMLS:C1310928


subject: UMLS:C1310928


subject: UMLS:C1310928


subject: UMLS:C1310928


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: UNII:Y64GQ0KC0A

subject_name: Teprotumumab

object_name: diabetic macular edema


subject: UMLS:C2346815


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: chronic otitis media


subject: UMLS:C0041044


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: Hospital acquired bacterial pneumonia


subject: PUBCHEM.COMPOUND:21014972

object_name: VABP


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:63638

subject_name: Vigabatrin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:63638

object_name: obesity


subject: CHEBI:63638

object_name: Obesity, CTCAE


subject: CHEBI:63638

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C3896672

subject_name: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3896672

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3896672

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C3896672

object_name: Stage IV Ovarian Cancer AJCC v8


subject: UMLS:C3896672

object_name: Ovarian cancer stage IV


subject: UMLS:C3896672

object_name: Stage IIIC Ovarian Cancer AJCC v8


subject: UMLS:C3896672

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C3896672

object_name: Stage IV Primary Peritoneal Cancer AJCC v8


subject: UMLS:C3896672

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: UMLS:C3896672

object_name: Stage IIIC Fallopian Tube Cancer AJCC v8


subject: UMLS:C3896672

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C3896672

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C3896672

object_name: Stage IV Fallopian Tube Cancer AJCC v8


subject: UMLS:C3896672

object_name: primary peritoneal serous adenocarcinoma


subject: UMLS:C3896672

object_name: peritoneal serous adenocarcinoma


subject: UMLS:C3896672

object_name: Fallopian Tube Serous Neoplasm


subject: UMLS:C3896672

object_name: fallopian tube endometrioid tumor


subject: UMLS:C3896672

object_name: fallopian tube mucinous tumor


subject: UMLS:C3896672

object_name: fallopian tube transitional cell carcinoma


subject: UMLS:C3896672

object_name: fallopian tube clear cell adenocarcinoma


subject: UMLS:C3896672

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UMLS:C3896672

object_name: ovarian transitional cell carcinoma


subject: UMLS:C3896672

object_name: undifferentiated ovarian carcinoma


subject: UMLS:C3896672

object_name: ovarian clear cell cystadenocarcinoma


subject: UMLS:C3896672

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C3896672

object_name: ovarian seromucinous carcinoma


subject: UMLS:C3896672

object_name: ovarian serous cystadenocarcinoma


subject: UMLS:C3896672

object_name: ovarian mucinous cystadenocarcinoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Rett syndrome


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: PUBCHEM.COMPOUND:70789201

subject_name: Telithromycin

object_name: Infection


subject: PUBCHEM.COMPOUND:70789201

object_name: Infection of musculoskeletal system


subject: PUBCHEM.COMPOUND:70789201

object_name: primary interstitial lung disease specific to childhood


subject: PUBCHEM.COMPOUND:70789201

object_name: interstitial lung disease specific to childhood


subject: UMLS:C0663674


subject: UMLS:C0663674


subject: UMLS:C0663674


subject: UMLS:C0663674


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Mild persistent asthma


subject: CHEBI:74705

object_name: Mild intermittent asthma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: essential hypertension


subject: CHEBI:131391


subject: CHEBI:23965

subject_name: estradiol

object_name: Menopausal and other perimenopausal disorders


subject: CHEBI:3380

subject_name: Captopril

object_name: hyperaldosteronism


subject: UMLS:C0006938

subject_name: captopril


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: UMLS:C0013227


subject: UMLS:C1254351


subject: CHEBI:77323

subject_name: Ethoxyquin

object_name: methamphetamine dependence


subject: CHEBI:48723

subject_name: Lobeline


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: myocardial infarction


subject: CHEBI:81579

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:81579

object_name: Myocardial Infarction by ECG Finding


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: inherited torticollis


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Torticollis


subject: UMLS:C2349192

subject_name: Pork Antigen

object_name: cardiovascular disorder


subject: UMLS:C4723950

subject_name: pork extract


subject: DRUGBANK:DB10561

subject_name: Pork


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: Chronic musculoskeletal pain


subject: PUBCHEM.COMPOUND:134210715

subject_name: TIVUMECIRNON

object_name: Advanced Melanoma


subject: UMLS:C4763501


subject: UMLS:C0445115

subject_name: Normal saline

object_name: Wound Infection


subject: UMLS:C0445115

object_name: Wound Infection, CTCAE


subject: UMLS:C3827133

subject_name: Anti-CD19 Monoclonal Antibody DI-B4

object_name: indolent B-cell non-Hodgkin lymphoma


subject: UMLS:C3827133

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C3827133

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: leukemia


subject: PUBCHEM.COMPOUND:131769963

object_name: childhood leukemia


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: MESH:C111756

subject_name: Essiac

object_name: ovarian cancer


subject: MESH:C111756

object_name: ovarian neoplasm


subject: MESH:C111756

object_name: ovarian carcinoma


subject: MESH:C111756

object_name: Childhood Breast Carcinoma


subject: MESH:C111756

object_name: breast carcinoma


subject: MESH:C111756

object_name: breast cancer


subject: UNII:T8B2ORP1DW

subject_name: Evinacumab

object_name: Hypercholesterolemia


subject: CHEBI:15367

subject_name: Tretinoin

object_name: malignant soft tissue neoplasm


subject: CHEBI:15367

object_name: sarcoma


subject: CHEBI:15367

object_name: leiomyosarcoma


subject: CHEBI:15367

object_name: Childhood Leiomyosarcoma


subject: CHEBI:15367

object_name: Adult Leiomyosarcoma


subject: UMLS:C1505595

object_name: adult lymphoma


subject: UMLS:C1505595

object_name: lymphoma


subject: UMLS:C1505595

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:122316

object_name: Alzheimer disease


subject: CHEBI:63620

subject_name: Rasagiline


subject: DRUGBANK:DB14744

subject_name: Spirulina platensis

object_name: Clumsiness - motor delay


subject: DRUGBANK:DB14744

object_name: Motor delay


subject: DRUGBANK:DB14744

object_name: pneumocystosis


subject: DRUGBANK:DB14744

object_name: hereditary endocrine growth disease


subject: DRUGBANK:DB14744

object_name: Underweight


subject: DRUGBANK:DB14744

object_name: malaria


subject: DRUGBANK:DB14744

object_name: Fever


subject: DRUGBANK:DB14744

object_name: Fever symptoms (finding)


subject: DRUGBANK:DB14744

object_name: Fever, CTCAE


subject: DRUGBANK:DB14744

object_name: Cough


subject: DRUGBANK:DB14744

object_name: Cough, CTCAE


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:46345

subject_name: Fluorouracil


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: GTOPDB:9596

subject_name: oleclumab


subject: GTOPDB:9596


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UNII:5CRY01URYQ


subject: UMLS:C4085967

subject_name: Oleclumab


subject: UMLS:C4085967


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: PUBCHEM.COMPOUND:9886134

subject_name: Branched chain amino acids

object_name: malnutrition


subject: UMLS:C0002521

subject_name: Amino Acids, Branched-Chain


subject: MESH:C054593

subject_name: keishibukuryogan

object_name: epilepsy


subject: UMLS:C2745432

subject_name: Meditoxin

object_name: dystonia


subject: MESH:D004043

subject_name: Dietary Fiber

object_name: benign neoplasm of large intestine


subject: MESH:D004043

object_name: Non-Neoplastic Anal Disorder


subject: CHEBI:10125

subject_name: Zolpidem

object_name: Consciousness Disorders


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Chronic iridocyclitis


subject: UMLS:C0304547

subject_name: Lactobacillus acidophilus preparation

object_name: Hay fever


subject: CHEMBL.COMPOUND:CHEMBL2109070

subject_name: LACTOBACILLUS ACIDOPHILUS


subject: CHEBI:6801

subject_name: Metformin

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:6801

object_name: vitiligo


subject: UMLS:C3502775

object_name: Carcinoma breast stage IV


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: Arrhythmia


subject: PUBCHEM.COMPOUND:91820602


subject: UNII:3CM03MUJ69

subject_name: Ingavirin

object_name: Acute respiratory infections


subject: UNII:3CM03MUJ69

object_name: influenza


subject: UNII:3CM03MUJ69

object_name: common cold


subject: UMLS:C5417893

subject_name: TGF-beta Receptor 1 Kinase Inhibitor YL-13027

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:119915

subject_name: Fentanyl

object_name: respiratory failure


subject: CHEBI:119915

object_name: Respiratory Failure, CTCAE


subject: CHEBI:119915

object_name: Sepsis


subject: CHEBI:119915

object_name: Sepsis, CTCAE


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915

object_name: Agitation, CTCAE 3.0


subject: CHEBI:44915

object_name: Agitation


subject: CHEBI:44915

object_name: Agitation, CTCAE 5.0


subject: PUBCHEM.COMPOUND:2269

object_name: periodontitis, chronic, adult


subject: PUBCHEM.COMPOUND:2269

object_name: chronic periodontitis


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: UNII:ZJA8LXP4EP

subject_name: LACTOBACILLUS RHAMNOSUS SP1


subject: UNII:ZJA8LXP4EP


subject: CHEBI:7553

subject_name: Niclosamide

object_name: rheumatoid arthritis


subject: CHEBI:16302


subject: UNII:81G40H8B0T

subject_name: VITAMIN A


subject: UMLS:C3714656

subject_name: Vitamin A Drug Class


subject: CHEBI:12777

subject_name: Vitamin A


subject: UMLS:C2825076

subject_name: Vitamin A [EPC]


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: Breastfeeding (mother)


subject: UMLS:C1815260

subject_name: Advate

object_name: hemophilia


subject: UMLS:C1815260

object_name: bone disorder


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Rash and Dermatitis Associated with Chemoradiation, CTCAE


subject: CHEBI:45863

subject_name: Paclitaxel


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C2981820

object_name: malignant peripheral nerve sheath tumor


subject: UMLS:C2981820

object_name: malignant soft tissue neoplasm


subject: UMLS:C2981820

object_name: sarcoma


subject: CHEBI:145373

subject_name: Pexidartinib


subject: CHEBI:145373


subject: CHEBI:145373


subject: CHEBI:9168

subject_name: Sirolimus


subject: UNII:B552L536ZL

object_name: inflammatory breast carcinoma


subject: UMLS:C2826356


subject: PUBCHEM.COMPOUND:16211421

subject_name: TALC

object_name: Malignant pleural effusion


subject: PR:000022710

subject_name: fructose-6-phosphate aldolase 2


subject: UMLS:C4508358

subject_name: ergoferon

object_name: viral respiratory tract infection


subject: UNII:4N9P6CC1DX

subject_name: Echinacea

object_name: Infection


subject: UNII:4N9P6CC1DX

object_name: Infection of musculoskeletal system


subject: UMLS:C5445960

subject_name: Echinacea antigen


subject: UMLS:C5445960


subject: CHEBI:18167

subject_name: alpha-maltose

object_name: hepatic encephalopathy


subject: CHEMBL.COMPOUND:CHEMBL2107951

subject_name: MALTODEXTRIN


subject: CHEBI:87681

subject_name: Ranolazine

object_name: Diabetic peripheral neuropathic pain


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Colorectal cancer stage II


subject: GTOPDB:12990

object_name: Colorectal cancer stage III


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: optic neuritis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: cardiovascular disorder


subject: DRUGBANK:DB10554

subject_name: Pear

object_name: abdominal obesity-metabolic syndrome


subject: DRUGBANK:DB10554

object_name: metabolic syndrome X


subject: UMLS:C5691041

object_name: Acute exacerbation of chronic obstructive pulmonary disease


subject: CHEBI:119915

subject_name: Fentanyl

object_name: cytokine release syndrome


subject: CHEBI:119915

object_name: Cytokine storm


subject: CHEBI:119915

object_name: morbid obesity


subject: CHEBI:119915

object_name: Fentanyl adverse reaction


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: endometrial cancer


subject: GTOPDB:9758

object_name: uterine corpus cancer


subject: GTOPDB:9758

object_name: endometrial carcinoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: CHEBI:4696

subject_name: donepezil hydrochloride

object_name: Presenile dementia


subject: CHEBI:4696

object_name: dementia


subject: UMLS:C4086713

subject_name: Substance with programmed cell death protein 1 inhibitor mechanism of action (substance)

object_name: nasopharyngeal carcinoma


subject: UMLS:C4086713

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:4672

subject_name: Docetaxel

object_name: liver cancer


subject: CHEBI:4672

object_name: liver neoplasm


subject: CHEBI:4672

object_name: Adult Liver Carcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Adverse effects in the therapeutic use of immunosuppressive agents


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:9168

subject_name: Sirolimus


subject: UMLS:C5226476

object_name: Drug Interactions


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Symptomatic COVID-19 Infection Laboratory-Confirmed


subject: CHEBI:17596

subject_name: Inosine

object_name: congenital heart disease


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:166975

subject_name: soybean oil

object_name: Cholestasis of parenteral nutrition


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: UMLS:C4275310

subject_name: SOYBEAN OIL 6 g in 100 mL / MEDIUM-CHAIN TRIGLYCERIDES 6 g in 100 mL / OLIVE OIL 5 g in 100 mL / FISH OIL 3 g in 100 mL INTRAVENOUS INJECTION, EMULSION


subject: PUBCHEM.COMPOUND:122173807

subject_name: anidulafungin

object_name: fungal lung infectious disease


subject: PUBCHEM.COMPOUND:122173807

object_name: Central Nervous System Fungal Infections


subject: PUBCHEM.COMPOUND:122173807

object_name: Fungemia


subject: PUBCHEM.COMPOUND:122173807

object_name: Fungemia, CTCAE


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: UMLS:C0532508


subject: CHEBI:62466

subject_name: Prolycopene

object_name: lichen planus, oral


subject: CHEBI:15948

subject_name: Lycopene


subject: CHEBI:27363

subject_name: Zinc

object_name: acne


subject: CHEBI:74067

subject_name: Ile-Ile


subject: PR:000001822

subject_name: MHC class II histocompatibility antigen gamma chain


subject: PR:000007904


subject: CHEBI:74705

subject_name: Met-Leu

object_name: central retinal vein occlusion with macular edema


subject: CHEBI:74705

object_name: Branch retinal vein occlusion with macular edema


subject: CHEBI:74705

object_name: diabetic macular edema


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:3A189DH42V

object_name: B-cell small lymphocytic lymphoma stage IV


subject: UNII:3A189DH42V

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UNII:3A189DH42V

object_name: B-cell small lymphocytic lymphoma stage III


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Chronic lymphocytic leukaemia stage 4


subject: CHEBI:135515


subject: CHEBI:135515

object_name: Chronic lymphocytic leukaemia stage 3


subject: CHEBI:135515


subject: GTOPDB:13085

subject_name: adebrelimab

object_name: digestive system cancer


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: CHEBI:9622

subject_name: Tolterodine

object_name: pelvic organ prolapse


subject: UMLS:C5706556

subject_name: KRAS G12C Inhibitor RMC-6291

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706556

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5203431

subject_name: Gemcitabine Liquid Injection

object_name: large B-cell lymphoma


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:6026

subject_name: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:6026

object_name: obesity


subject: PUBCHEM.COMPOUND:6026

object_name: Obesity, CTCAE


subject: CHEBI:3165

subject_name: Bradykinin


subject: CHEBI:3165


subject: CHEBI:3165


subject: CHEBI:132988


subject: CHEBI:132988


subject: CHEBI:132988


subject: UNII:S8TIM42R2W

subject_name: BRADYKININ


subject: UNII:S8TIM42R2W


subject: UNII:S8TIM42R2W


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: PUBCHEM.COMPOUND:11559429

object_name: Stress urinary incontinence


subject: UNII:A6XE99NLS9


subject: CHEBI:174615

object_name: Disorder related to bone marrow transplantation


subject: CHEBI:28901


subject: CHEBI:681569

subject_name: Clofarabine


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:93775

subject_name: Amethopterin

object_name: transplantation infection


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: gastric adenocarcinoma


subject: UMLS:C2828372


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED

object_name: maxillary sinusitis


subject: MESH:C539069

subject_name: smallpox vaccine LC16m8

object_name: smallpox


subject: CHEBI:567361

subject_name: Cladribine

object_name: High Risk Acute Myeloid Leukemia


subject: CHEBI:63606

subject_name: Levoleucovorin

object_name: Blood Pressure Finding


subject: CHEBI:63606

object_name: Systemic arterial pressure


subject: CHEBI:63606

object_name: Vascular Stiffness


subject: CHEBI:35255

subject_name: Chloroform


subject: CHEBI:35255


subject: CHEBI:35255


subject: CHEBI:33392

subject_name: Californium


subject: CHEBI:33392


subject: CHEBI:33392


subject: UNII:14J2G0U3NQ

subject_name: Laromustine

object_name: lung cancer


subject: UNII:14J2G0U3NQ

object_name: lung neoplasm


subject: UNII:14J2G0U3NQ

object_name: lung carcinoma


subject: GTOPDB:13718

subject_name: xaluritamig

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:ODG03B9M4U

subject_name: XALURITAMIG


subject: UMLS:C5238964

subject_name: Xaluritamig


subject: UMLS:C3181507

object_name: diffuse cutaneous systemic sclerosis


subject: UMLS:C3181507

object_name: diffuse scleroderma


subject: CHEBI:73286

subject_name: Piclidenoson

object_name: Chronic small plaque psoriasis


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: urinary tract infection


subject: DRUGBANK:DB19282

object_name: Recurrent urinary tract infections


subject: CHEBI:49140

object_name: Thromboembolism of vein


subject: CHEBI:49140

object_name: Special screening finding


subject: CHEBI:49140

object_name: Deep Venous Thrombosis Related to COVID-19


subject: CHEBI:49140

object_name: Deep venous thrombosis


subject: CHEBI:49140

object_name: lung disorder


subject: CHEBI:49140

object_name: History of - respiratory disease


subject: CHEBI:49140

object_name: respiratory system disorder


subject: CHEBI:49140

object_name: pulmonary embolism


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: CHEBI:31617


subject: UMLS:C0308813

subject_name: DEXTROSE 5% IN SALINE 0.9%

object_name: Hyponatremia


subject: UMLS:C0308813

object_name: Hyponatremia, CTCAE


subject: UNII:6VP6PBL1ZH

object_name: acute inflammatory response to non-antigenic stimulus


subject: UMLS:C4043114


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: Breakthrough Infections


subject: UNII:JSV288Q5CV

object_name: Immunocompromised Host


subject: UNII:5085ZFP6SJ

subject_name: TOZINAMERAN


subject: UNII:5085ZFP6SJ


subject: UMLS:C5671093

subject_name: NFX-179 Gel

object_name: Cutaneous neurofibroma


subject: UMLS:C5671093

object_name: neurofibromatosis 1


subject: UMLS:C5671093

object_name: neurofibromatosis type 1


subject: CHEBI:32599

object_name: Post-Dural Puncture Headaches


subject: CHEBI:73806

subject_name: Ala-Met

object_name: chronic kidney disease


subject: CHEBI:73806

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:33389

subject_name: americium atom


subject: CHEBI:33389


subject: PR:000004405

subject_name: activating transcription factor 7-interacting protein 1


subject: PR:000004405


subject: PR:000003781

subject_name: pro-adrenomedullin


subject: PR:000003781


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Allergy


subject: CHEBI:8884

object_name: hypersensitivity reaction disease


subject: MESH:C421461

subject_name: glubran 2

object_name: Pancreatic fistula


subject: MESH:C421461

object_name: Pancreatic Fistula, CTCAE


subject: MESH:C421461

object_name: Periampullary carcinoma NOS


subject: CHEBI:230430

subject_name: Ulinastatin

object_name: Severe Sepsis


subject: CHEBI:230430

object_name: septic shock


subject: CHEBI:230430

object_name: multiple organ dysfunction syndrome


subject: UNII:OR3S9IF86U

subject_name: urinastatin


subject: UNII:OR3S9IF86U


subject: UNII:OR3S9IF86U


subject: CHEMBL.COMPOUND:CHEMBL2108163

subject_name: ULINASTATIN


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: CHEMBL.COMPOUND:CHEMBL2108163


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UMLS:C0077906


subject: UNII:71492GE1FX

subject_name: Benralizumab

object_name: Severe asthma


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: retroperitoneal sarcoma


subject: UMLS:C1879771

subject_name: BIBF 1120

object_name: interstitial lung disease 1


subject: UMLS:C1879771

object_name: interstitial lung disease 2


subject: MESH:C000708357

subject_name: weifuchun

object_name: gastric cancer


subject: UMLS:C5392569


subject: CHEBI:92223

subject_name: Abexinostat

object_name: Recurrent Malignant Glioma


subject: CHEBI:92223

object_name: Childhood Anaplastic Oligodendroglioma


subject: CHEBI:92223

object_name: anaplastic oligodendroglioma


subject: CHEBI:92223

object_name: Adult Anaplastic Oligodendroglioma


subject: CHEBI:92223

object_name: Grade III Childhood Astrocytoma


subject: CHEBI:92223

object_name: Adult Anaplastic Astrocytoma


subject: CHEBI:92223

object_name: anaplastic astrocytoma


subject: CHEBI:92223

object_name: glioblastoma


subject: CHEBI:92223

object_name: Childhood Glioblastoma


subject: CHEBI:92223

object_name: adult glioblastoma


subject: CHEBI:92223

object_name: Adult Gliosarcoma


subject: CHEBI:92223

object_name: gliosarcoma


subject: CHEBI:92223

object_name: Childhood Gliosarcoma


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: UMLS:C2003604


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: adenoid cystic carcinoma


subject: UMLS:C1314412

subject_name: INJECTION, ALEFACEPT, 0.5 MG ADMINISTERED

object_name: chronic graft versus host disease


subject: UNII:ELK3V90G6C

subject_name: Alefacept


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL

object_name: dermatitis


subject: CHEMBL.COMPOUND:CHEMBL2107910

object_name: Dermatitis


subject: UNII:ZH5SMU97AJ

object_name: inherited susceptibility to asthma


subject: UNII:ZH5SMU97AJ

object_name: asthma


subject: UNII:ZH5SMU97AJ

object_name: respiratory system disorder


subject: UNII:ZH5SMU97AJ

object_name: Bronchospasm


subject: UMLS:C4521107

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C4521107

object_name: aplastic anemia


subject: UMLS:C4521107

object_name: idiopathic aplastic anemia


subject: UMLS:C4521107

object_name: Hypoplastic myelodysplastic syndrome


subject: CHEBI:201431

subject_name: Cyclosporin H


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UMLS:C0004149

subject_name: ATGAM


subject: PUBCHEM.COMPOUND:166625217

subject_name: MOTIXAFORTIDE


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:166625217


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:21014972

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:21014972

object_name: kidney disorder


subject: CHEBI:177700

subject_name: Elacytarabine

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:177700

object_name: acute myeloid leukemia


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: periventricular nodular heterotopia


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: GTOPDB:13692

subject_name: mitazalimab

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEMBL.COMPOUND:CHEMBL4297870

subject_name: MITAZALIMAB


subject: UMLS:C4053684


subject: UNII:I4ZSB1Q2DU

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:I4ZSB1Q2DU

object_name: amyotrophic lateral sclerosis


subject: CHEMBL.COMPOUND:CHEMBL4297561


subject: CHEMBL.COMPOUND:CHEMBL4297561


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: retinopathy of prematurity


subject: UMLS:C3714803

object_name: exudative vitreoretinopathy 1


subject: UMLS:C3714803

object_name: Retinopathy of Prematurity, AE


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: CHEBI:64019

subject_name: Nebivolol

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: CHEBI:64019

object_name: Left ventricular diastolic dysfunction


subject: UMLS:C3896906

object_name: lung cancer


subject: UMLS:C3896906

object_name: lung neoplasm


subject: UMLS:C3896906

object_name: lung carcinoma


subject: UMLS:C0981930

subject_name: ALLERGENIC EXTRACT, MOUSE

object_name: asthma


subject: UMLS:C0981930

object_name: Atopic rhinitis


subject: UMLS:C0981930

object_name: perennial allergic rhinitis


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Acute Stroke


subject: CHEBI:5118

object_name: Acute Stroke Related to COVID-19


subject: CHEBI:5118

object_name: Visual field defect


subject: CHEBI:73611

subject_name: Met-Gly

object_name: reproductive issues


subject: CHEBI:73611

object_name: Reproductive History


subject: CHEBI:73611

object_name: Transsexualism


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: PR:000004501

subject_name: attractin


subject: PR:000004501


subject: PR:000004501


subject: UMLS:C0487173

subject_name: Mg antigen


subject: UMLS:C0487173


subject: UMLS:C0487173


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: UMLS:C0731161

subject_name: Glucagon Lilly

object_name: type 1 diabetes mellitus 1


subject: UMLS:C0731161

object_name: type 1 diabetes mellitus


subject: UMLS:C0731161

object_name: Insulin hypoglycaemia


subject: UMLS:C0731161

object_name: Severe hypoglycaemia


subject: CHEMBL.COMPOUND:CHEMBL2109426

object_name: plasma cell myeloma


subject: UMLS:C2698143


subject: UMLS:C3640806

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:229764

subject_name: Selinexor


subject: RXCUI:198335

subject_name: sulfamethoxazole 800 MG / trimethoprim 160 MG Oral Tablet

object_name: Antibiotic resistant infection


subject: RXCUI:198335

object_name: Unspecified antibiotic causing adverse effects in therapeutic use


subject: RXCUI:198335

object_name: urinary tract infection


subject: RXCUI:198335

object_name: bacterial urinary tract infection


subject: RXCUI:198335

object_name: microtia


subject: RXCUI:198335

object_name: bacteriuria


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Indolent Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Aggressive Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: UMLS:C3152625

subject_name: Pneumococcal 13-valent conjugate vaccine


subject: UMLS:C3152625


subject: UMLS:C3152625

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UMLS:C3152625

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UMLS:C3152625

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UMLS:C3152625


subject: UMLS:C3152625


subject: UMLS:C3152625

object_name: T-cell lymphoma recurrent


subject: UMLS:C3152625

object_name: Mantle cell lymphoma recurrent


subject: UMLS:C3152625

object_name: Follicular lymphoma recurrent


subject: UMLS:C3152625

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C3152625

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C3152625

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: CHEBI:34945

object_name: Opioid-Induced Bowel Dysfunction


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: CHEBI:3077

subject_name: Betamethasone

object_name: Acquired phimosis


subject: CHEBI:3077

object_name: phimosis


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: UMLS:C5417918

object_name: Adult Solid Neoplasm


subject: UMLS:C5417917


subject: PUBCHEM.COMPOUND:3222

object_name: lung cancer


subject: PUBCHEM.COMPOUND:3222

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:3222

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:3222

object_name: radiation pneumonitis


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:28241

subject_name: Papaverine

object_name: renal carcinoma


subject: CHEBI:28241

object_name: kidney neoplasm


subject: CHEBI:28241

object_name: kidney cancer


subject: CHEBI:7865

subject_name: Oxymorphone

object_name: chronic pain (diagnosis)


subject: CHEBI:7865

object_name: Chronic pain


subject: GTOPDB:2479

subject_name: HCl


subject: GTOPDB:2479


subject: GTOPDB:2479

object_name: Post-Operative Pain


subject: UMLS:C1512523

subject_name: hydrochloride


subject: UMLS:C1512523


subject: UMLS:C1512523


subject: UMLS:C0443985

subject_name: Flinders medical centre-7 marker


subject: UMLS:C0443985


subject: UMLS:C0443985


subject: CHEBI:17883

subject_name: Hydrochloric acid


subject: CHEBI:17883


subject: CHEBI:17883


subject: UNII:O4BT6C02M2

subject_name: Zetomipzomib

object_name: lupus nephritis


subject: UNII:O4BT6C02M2

object_name: EXCESS LMW-DNA


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: TRANSPLANTS AND IMPLANTS


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8382

subject_name: Prednisone


subject: DRUGBANK:DB14690

subject_name: Ginger oil

object_name: Periodontal Pocket


subject: PUBCHEM.COMPOUND:46174089

subject_name: GLUCOSAMINE SULFATE


subject: CHEBI:28393

subject_name: D-glucosamine


subject: CHEBI:37878

subject_name: glucosamine sulfate


subject: CHEBI:20993

subject_name: GLUCOSAMINE


subject: CHEBI:50692

subject_name: Mifepristone

object_name: anxiety disorder


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Immunosuppression


subject: CHEBI:231614

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:231614

object_name: AIDS


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:177298

object_name: ovarian carcinosarcoma


subject: CHEBI:177298

object_name: Endometrial carcinosarcoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab


subject: UNII:P0GVQ9A4S5


subject: CHEBI:90942

subject_name: Ixazomib

object_name: Relapsed/refractory multiple myeloma


subject: CHEBI:6432

subject_name: Levamisole

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:6432

object_name: cirrhosis, familial


subject: CHEBI:6432

object_name: Radicular Cyst


subject: CHEBI:22586

subject_name: antioxidant

object_name: Postoperative cardiac complication


subject: UMLS:C0003402

subject_name: Antioxidants


subject: CHEBI:25805

subject_name: oxygen atom


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:8884

subject_name: Rocuronium

object_name: self-limited epilepsy with centrotemporal spikes


subject: CHEBI:45652

subject_name: Succinylcholine


subject: CHEBI:68554

subject_name: Deferiprone

object_name: Presenile dementia


subject: CHEBI:68554

object_name: dementia


subject: CHEBI:52854

subject_name: gold nanocrystal

object_name: Parkinson disease


subject: CHEMBL.COMPOUND:CHEMBL2108334

subject_name: Coagulation factor VIIa Recombinant Human

object_name: hemophilia B


subject: UMLS:C0593103

subject_name: Novoseven


subject: PR:000007301

subject_name: coagulation factor VII


subject: PR:000007301

object_name: hemophilia A


subject: UNII:2F6ZF5WYCC

subject_name: vatreptacog alfa


subject: UNII:2F6ZF5WYCC


subject: UNII:2F6ZF5WYCC

object_name: Congenital Bleeding Disorder


subject: UMLS:C4044785


subject: UMLS:C4044785


subject: UMLS:C4044785


subject: PUBCHEM.COMPOUND:3080587

subject_name: Megestrol


subject: PUBCHEM.COMPOUND:3080587


subject: PUBCHEM.COMPOUND:56843330

subject_name: upamostat


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate

object_name: non-Hodgkin lymphoma


subject: UMLS:C0054066

object_name: leukemia


subject: UMLS:C0054066

object_name: childhood leukemia


subject: UMLS:C0054066

object_name: plasma cell myeloma


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Pneumonia caused by SARS-CoV-2


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE

object_name: melanoma


subject: CHEBI:43830

subject_name: Methylthioninium


subject: MESH:C000615519


subject: MESH:C000615519

object_name: Sentinel node (disorder)


subject: CHEBI:33353

subject_name: technetium atom


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Vaginal delivery (finding)


subject: CHEBI:3614

object_name: previous vaginal delivery (history)


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Maternity blues


subject: CHEBI:60802

subject_name: ropivacaine


subject: UNII:4B33BGI082

subject_name: Cholestyramine

object_name: Hypercholesterolemia


subject: CHEBI:38562

subject_name: Fluvastatin


subject: PUBCHEM.COMPOUND:3962


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:46692

object_name: Severe Sepsis


subject: UMLS:C2984541

subject_name: Eritoran Tetrasodium


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Bedwetting


subject: CHEBI:6887

object_name: enuresis


subject: CHEBI:6887

object_name: Urinary incontinence of non-organic origin


subject: CHEBI:6887

object_name: Urinary incontinence


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole

object_name: urothelial carcinoma


subject: UNII:5YV419FIJS

object_name: transitional cell carcinoma


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: perinatal asphyxia


subject: CHEBI:73604

object_name: Neonatal hypoxic and ischemic brain injury


subject: CHEBI:73604

object_name: Hypoxic-Ischemic Encephalopathy


subject: CHEBI:73604

object_name: Hypoxic Ischemic Encephalopathy, AE


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: bladder tumor


subject: CHEBI:233362

object_name: urinary bladder carcinoma


subject: CHEBI:233362

object_name: urinary bladder cancer


subject: CHEBI:233362

object_name: childhood bladder carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:184067

subject_name: L-leucyl-l-leucine methyl ester


subject: UMLS:C0281255

subject_name: L-Leucyl-L-Leucine Methyl Ester


subject: UMLS:C1327972

subject_name: Fowlpox-PSA-TRICOM Vaccine

object_name: prostate neoplasm


subject: UMLS:C5848411

subject_name: CDK4/6 Inhibitor G1T38

object_name: Advanced breast cancer


subject: CHEBI:193615

object_name: gastric adenocarcinoma


subject: CHEBI:60761

subject_name: Floxuridine


subject: UMLS:C0677671

subject_name: Leuvectin

object_name: prostate carcinoma


subject: UMLS:C0677671

object_name: prostate cancer


subject: UMLS:C1831903

object_name: colon cancer liver metastasis


subject: UMLS:C1831904

subject_name: ThermoDox


subject: UMLS:C4019381

subject_name: Granulocyte component of blood

object_name: Advanced cancer


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: torsion dystonia 7


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: Acne inversa


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Gastroesophageal junction cancer


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:83766

subject_name: Olaparib

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: UMLS:C2346816

object_name: liver carcinoma


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: candidiasis


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:125400

subject_name: actinomycin D

object_name: neoplasm of testis


subject: CHEBI:125400

object_name: testicular cancer


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: CHEBI:83527

subject_name: Desvenlafaxine

object_name: social phobia


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Pain Disorder


subject: UMLS:C4086546

object_name: sweet syndrome


subject: UMLS:C4086546

object_name: Vomiting, CTCAE


subject: UMLS:C4086546

object_name: Vomiting


subject: UMLS:C4086546

object_name: dizziness


subject: UMLS:C4086546

object_name: Dizziness, CTCAE 5.0


subject: UMLS:C4086546

object_name: Dizziness, CTCAE 3.0


subject: UMLS:C4086546

object_name: Pruritus


subject: UMLS:C4086546

object_name: common cold


subject: UMLS:C4086546

object_name: Upper Respiratory Infections


subject: UMLS:C4086546

object_name: chronic obstructive pulmonary disease


subject: CHEBI:16452

subject_name: Oxalacetate

object_name: Parkinson disease


subject: MESH:D010071

subject_name: Oxaloacetates


subject: CHEBI:30744

subject_name: OXALOACETATE


subject: CHEBI:132560

subject_name: oligo(amidoamine)


subject: CHEBI:75551

object_name: epilepsy


subject: UMLS:C5706509

subject_name: Anti-CD79b/CD20/CD3 Trispecific Antibody JNJ-80948543

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:47426

subject_name: Furosemide

object_name: Transfusion associated circulatory overload


subject: UMLS:C0699617

subject_name: Norditropin

object_name: Congenital IGHD


subject: UMLS:C0699617

object_name: Reduced circulating growth hormone concentration


subject: CHEMBL.COMPOUND:CHEMBL4650377

object_name: Cachexia


subject: UMLS:C5854587

subject_name: Rilogrotug


subject: MESH:C000726227

object_name: treatment-refractory schizophrenia


subject: CHEBI:94534

subject_name: olanzapine


subject: CHEBI:8871

subject_name: Risperidone


subject: UNII:IY90U61Z3S

subject_name: ARGATROBAN

object_name: Extracorporeal membrane oxygenation complication


subject: UNII:IY90U61Z3S

object_name: Anticoagulants and Bleeding Disorders


subject: UNII:0DW7MIH1VX

subject_name: Argatroban


subject: UNII:0DW7MIH1VX


subject: CHEBI:48720

subject_name: argatroban


subject: CHEBI:48720


subject: CHEBI:195558

subject_name: Entrectinib

object_name: liver failure


subject: UMLS:C5226607

object_name: psoriasis


subject: PUBCHEM.COMPOUND:127236

object_name: Plasma cell myeloma refractory


subject: PR:000001406

subject_name: tumor necrosis factor receptor superfamily member 17


subject: UMLS:C3254127

subject_name: polyethylene glycol-recombinant human growth hormone

object_name: Dwarfism


subject: UMLS:C3254127

object_name: Short stature


subject: UMLS:C3254127

object_name: Short Stature, CTCAE


subject: CHEBI:85182

subject_name: Dasabuvir

object_name: HIV infection


subject: CHEBI:85188

subject_name: paritaprevir


subject: PUBCHEM.COMPOUND:76192587

subject_name: Ombitasvir


subject: CHEBI:32090

subject_name: Rebamipide

object_name: Heartburn


subject: UMLS:C5557449

object_name: Plexosarcoma


subject: CHEMBL.COMPOUND:CHEMBL2108102

subject_name: ST. JOHN'S WORT

object_name: Uses contraception (finding)


subject: UMLS:C3274746

subject_name: PVS-RIPO

object_name: Adult Gliosarcoma


subject: UMLS:C3274746

object_name: gliosarcoma


subject: UMLS:C3274746

object_name: Childhood Gliosarcoma


subject: UMLS:C3274746

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C3274746

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C3274746

object_name: anaplastic astrocytoma


subject: UMLS:C3274746

object_name: Childhood Anaplastic Oligodendroglioma


subject: UMLS:C3274746

object_name: anaplastic oligodendroglioma


subject: UMLS:C3274746

object_name: Adult Anaplastic Oligodendroglioma


subject: UMLS:C3274746

object_name: Childhood Anaplastic Oligoastrocytoma


subject: UMLS:C3274746

object_name: anaplastic oligoastrocytoma


subject: UMLS:C3274746

object_name: Pleomorphic xanthoastrocytoma of brain


subject: UMLS:C3274746

object_name: medulloblastoma


subject: UMLS:C3274746

object_name: childhood medulloblastoma


subject: UMLS:C3274746

object_name: adult medulloblastoma


subject: UMLS:C3274746

object_name: atypical teratoid/rhabdoid tumor of brain


subject: UMLS:C3274746

object_name: Embryonal tumor of brain


subject: UMLS:C3274746

object_name: glioma susceptibility 1


subject: UMLS:C3274746

object_name: ependymoma


subject: UMLS:C3274746

object_name: childhood ependymoma


subject: UMLS:C3274746

object_name: Newly Diagnosed Childhood Ependymoma


subject: UMLS:C3274746

object_name: Adult Ependymoma


subject: CHEBI:53760

subject_name: Eszopiclone

object_name: endogenous depression


subject: CHEBI:53760

object_name: major depressive disorder


subject: CHEBI:149509

object_name: methamphetamine dependence


subject: CHEBI:149509

object_name: Harmful pattern of use of methamphetamine


subject: CHEBI:149509

object_name: Harmful pattern of substance use


subject: CHEBI:149509

object_name: substance abuse


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:8024

subject_name: Perindopril


subject: CHEBI:8024


subject: CHEBI:8024


subject: CHEBI:8024


subject: CHEBI:177705

subject_name: Birinapant

object_name: hepatitis B


subject: UMLS:C2981814


subject: UNII:54534MX6Z9

subject_name: Teclistamab

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C4527013


subject: UMLS:C4724867

subject_name: Zirconium Zr 89 Pembrolizumab

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:9914270

subject_name: Landiolol

object_name: dysautonomia


subject: PUBCHEM.COMPOUND:9914270

object_name: autonomic nervous system disorder


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: cardiotoxicity


subject: UNII:C8ADC441ME

object_name: Effects of chemotherapy


subject: UNII:C8ADC441ME

object_name: neoplasm


subject: CHEBI:145374

subject_name: Enasidenib

object_name: Recurrent Carcinoma


subject: CHEBI:145374

object_name: refractory malignant neoplasm


subject: CHEBI:145374

object_name: IDH2 gene mutation


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:133021


subject: UMLS:C0770694

subject_name: trivalent influenza vaccine

object_name: acute myocardial infarction


subject: UMLS:C0770694

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0770694

object_name: Inflammatory Response


subject: UMLS:C0770694

object_name: cardiovascular disorder


subject: MESH:D007252

subject_name: Influenza Vaccines


subject: MESH:D007252


subject: MESH:D007252


subject: MESH:D007252


subject: UMLS:C5395271

subject_name: Vaccine product containing only Influenza virus antigen (medicinal product)


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: UMLS:C5395271


subject: CHEBI:64312

subject_name: Memantine

object_name: Solid Neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: carotid stenosis


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:87631

object_name: stroke disorder


subject: CHEBI:9150

subject_name: Simvastatin


subject: UMLS:C0003250

subject_name: Monoclonal Antibodies

object_name: Wounds and Injuries


subject: UMLS:C0003250

object_name: Amputation, Traumatic


subject: UMLS:C0003250

object_name: Amputated structure (morphologic abnormality)


subject: UMLS:C5203232

subject_name: Monoclonal Antibody [EPC]


subject: UMLS:C5203232


subject: UMLS:C5203232


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:84500

subject_name: varenicline

object_name: schizophreniform disorder


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: Increased reactive oxygen species production


subject: CHEBI:75551


subject: UMLS:C0115922

subject_name: endogenous pyrogen


subject: PR:000059798

subject_name: ciliary microtubule-associated protein 2


subject: UNII:L33EX3XR0T

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UNII:L33EX3XR0T

object_name: Cerebral Vasospasm


subject: UNII:L33EX3XR0T

object_name: Delayed cerebral ischaemia


subject: UNII:L33EX3XR0T

object_name: coronary microvascular disorder


subject: UMLS:C3713989


subject: UMLS:C3713989


subject: UMLS:C3713989


subject: UMLS:C3713989


subject: UMLS:C2241628

subject_name: aliskiren / hydrochlorothiazide

object_name: hypertension


subject: UMLS:C2241628

object_name: Hypertension, CTCAE


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: plasma cell myeloma


subject: UMLS:C3896947

subject_name: Fluorine F 18 Ara-G

object_name: Advanced Lung Non-Small Cell Carcinoma


subject: UMLS:C3896947

object_name: Stage IV Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Stage IVB Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Stage III Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UMLS:C3896947

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UMLS:C3896947

object_name: Stage IIIB Lung Cancer AJCC v8


subject: CHEBI:75958

subject_name: solution

object_name: COPD, severe early onset


subject: CHEBI:75958

object_name: chronic obstructive pulmonary disease


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Localized Unresectable Adult Hepatocellular Carcinoma


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: ischemia


subject: UNII:ZL1R02VT79

object_name: Pathologic Processes


subject: CHEBI:47426

subject_name: Furosemide

object_name: Transitory tachypnea of newborn


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: renal carcinoma


subject: CHEBI:63791

object_name: kidney neoplasm


subject: CHEBI:63791

object_name: kidney cancer


subject: CHEBI:50169

subject_name: Brexanolone

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:50169

object_name: alcohol abuse


subject: CHEBI:50169

object_name: alcohol dependence


subject: CHEBI:51230

subject_name: Bimatoprost

object_name: OPTN-related open angle glaucoma


subject: UMLS:C4308025

subject_name: AAA 617

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C4308025

object_name: metastatic prostate carcinoma


subject: UMLS:C5784759

subject_name: niraparib + abiraterone acetate


subject: UMLS:C5784759

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5784759


subject: PUBCHEM.COMPOUND:91867649

object_name: REM sleep behavior disorder


subject: PUBCHEM.COMPOUND:91867649

object_name: Parkinson disease


subject: CHEBI:36929

subject_name: carbon-11 atom


subject: CHEBI:36929


subject: UNII:CVO3TI9K02


subject: UNII:CVO3TI9K02


subject: PUBCHEM.COMPOUND:22896913

subject_name: Ioflupane


subject: PUBCHEM.COMPOUND:22896913


subject: PUBCHEM.COMPOUND:48175

subject_name: Halobetasol Propionate

object_name: Chronic small plaque psoriasis


subject: UNII:JJX4JHS4PO

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C2346687


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: GTOPDB:8221

subject_name: epacadostat


subject: UNII:2HR315841W


subject: CHEBI:8802

subject_name: Remifentanil

object_name: aortic stenosis


subject: CHEBI:8802

object_name: myocardial ischemia


subject: CHEBI:9316

subject_name: Sufentanil


subject: CHEBI:9316


subject: CHEBI:9316

object_name: coronary atherosclerosis


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: MALT lymphoma


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Epilepsy in children


subject: CHEBI:16796

subject_name: Melatonin


subject: UMLS:C5700219

subject_name: Therapeutic allogeneic lymphocytes

object_name: lymphoproliferative syndrome


subject: CHEBI:30145

subject_name: lithium atom

object_name: long COVID-19


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: UNII:1C6V77QF41

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: UNII:1C6V77QF41

object_name: adult acute myeloid leukemia with del(5q)


subject: UNII:1C6V77QF41

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: UNII:1C6V77QF41

object_name: Untreated Adult Acute Myeloid Leukemia


subject: UNII:1C6V77QF41

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: UNII:1C6V77QF41

object_name: Adult Acute Myelomonocytic Leukemia


subject: UNII:1C6V77QF41

object_name: Adult Pure Erythroid Leukemia


subject: UNII:1C6V77QF41

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: UNII:1C6V77QF41

object_name: adult acute monocytic leukemia


subject: UNII:1C6V77QF41

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: UNII:1C6V77QF41

object_name: Adult Acute Monoblastic Leukemia


subject: UNII:1C6V77QF41

object_name: acute megakaryoblastic leukemia in adult


subject: UNII:1C6V77QF41

object_name: Adult Erythroleukemia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:66964

subject_name: Dronabinol

object_name: pancreatic neoplasm


subject: CHEBI:66964

object_name: Malignant cachexia


subject: CHEBI:66964

object_name: mortality


subject: CHEBI:66964

object_name: Morbidity


subject: CHEBI:6128

subject_name: Ketoprofen

object_name: Ankle Sprains


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: urothelial carcinoma


subject: PR:000014196

object_name: transitional cell carcinoma


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: temporal arteritis


subject: CHEBI:67271

object_name: Stage IVB Rectal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVB Rectal Cancer AJCC v8


subject: CHEBI:67271

object_name: stage IVB rectal cancer


subject: CHEBI:67271

object_name: stage IVA rectal cancer


subject: CHEBI:67271

object_name: Stage IVA Rectal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVA Rectal Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIC Rectal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIC Rectal Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:67271

object_name: stage IIIA rectal cancer


subject: CHEBI:67271

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIC Colon Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIC Colon Cancer AJCC v7


subject: CHEBI:67271

object_name: stage IVA colon cancer


subject: CHEBI:67271

object_name: Stage IVA Colon Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVA Colon Cancer AJCC v8


subject: CHEBI:67271

object_name: stage IVB colon cancer


subject: CHEBI:67271

object_name: Stage IVB Colon Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IVB Colon Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIA Colon Cancer AJCC v7


subject: CHEBI:67271

object_name: Stage IIIA Colon Cancer AJCC v8


subject: CHEBI:67271

object_name: malignant large intestine neoplasm stage IIIb


subject: CHEBI:67271

object_name: Stage IIIB Colon Cancer AJCC v8


subject: CHEBI:67271

object_name: Stage IIIB Colon Cancer AJCC v7


subject: CHEBI:67271

object_name: Recurrent Rectal Cancer


subject: CHEBI:67271

object_name: rectal signet ring cell adenocarcinoma


subject: CHEBI:67271

object_name: colon signet ring cell adenocarcinoma


subject: CHEBI:67271

object_name: Colon cancer recurrent


subject: CHEBI:67271

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:67271

object_name: colon mucinous adenocarcinoma


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Pain, Procedural


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C2353170

object_name: myelofibrosis


subject: CHEBI:3310

subject_name: Calcium acetate

object_name: arteriosclerosis disorder


subject: CHEBI:3310

object_name: calcinosis


subject: CHEBI:3310

object_name: secondary hyperparathyroidism


subject: CHEBI:8884

subject_name: Rocuronium

object_name: Inguinal hernia


subject: UMLS:C1882963

object_name: radiation exposure measurement


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: chronic pain (diagnosis)


subject: CHEBI:150712

object_name: Chronic pain


subject: CHEBI:150712

object_name: Intraarticular (intended site)


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: UNII:7UQ7X4Y489

subject_name: TINZAPARIN

object_name: Pneumonia caused by SARS-CoV-2


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:8378

subject_name: Prednisolone

object_name: reported history of cataract surgery


subject: CHEBI:135552

subject_name: Prucalopride

object_name: Depressive disorder in remission


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Chronic pulmonary aspergillosis


subject: CHEBI:76611

subject_name: flutemetamol

object_name: Alzheimer disease


subject: CHEBI:50381

subject_name: Miglustat

object_name: Gaucher disease type I


subject: UMLS:C2069057

subject_name: premixed insulin

object_name: type 2 diabetes mellitus


subject: CHEBI:8871

subject_name: Risperidone

object_name: diabetes mellitus


subject: CHEBI:79033

subject_name: florbetaben F18

object_name: AL amyloidosis


subject: CHEBI:157844

subject_name: Glu-Arg

object_name: pneumonia


subject: CHEBI:157844

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:33379

subject_name: erbium


subject: CHEBI:33379


subject: UMLS:C5441529

subject_name: Estrogen Receptor Family, human


subject: UMLS:C5441529


subject: PR:000007204

subject_name: estrogen receptor


subject: PR:000007204


subject: CHEBI:187893

subject_name: Baclofen

object_name: post-traumatic stress disorder


subject: CHEBI:71272

subject_name: Saxagliptin

object_name: coronary artery disorder


subject: CHEBI:71272

object_name: coronary atherosclerosis


subject: CHEBI:71272

object_name: maturity-onset diabetes of the young type 1


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: Urothelial carcinoma recurrent


subject: UNII:6T4O391P5Y

object_name: Advanced Urothelial Carcinoma


subject: UMLS:C3896757

subject_name: TGFBR1 Inhibitor TEW-7197


subject: UMLS:C3896757


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C4305727

object_name: Rhinovirus infection


subject: GTOPDB:5962

subject_name: dovitinib

object_name: Pleural mesothelioma malignant advanced


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: dry eye syndrome


subject: UMLS:C0085297

object_name: Dry Eye, CTCAE


subject: UMLS:C0085297

object_name: Dryness of eye


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:06P3KLK2J8

object_name: Childhood Non-Hodgkin Lymphoma